poisar

Stocks · News reference

Gyre Therapeutics Enters Employment Agreement with Ying Luo as CEO

Fiscal.ai

Gyre Therapeutics, Inc. has entered into an employment agreement with Ying Luo to serve as the company's Chief Executive Officer.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — GYRE THERAPEUTICS, INC. (GYRE)

    Filed: 2026-11-05 AccNo: 0001193125-26-449985 Size: 13 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits